Post-treatment Surveillance in HPV+ Oropharyngeal SCC

Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer

NCT04574635 ·Status: ACTIVE_NOT_RECRUITING

ctDNA Liquid Biopsy for Early Assessment of Residual Disease in HPV-associated Head and Neck Cancer (Clear-HPVca)

NCT06730412 ·Status: COMPLETED

Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)

NCT02045186 ·Status: TERMINATED ·Phase: NA

Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention

NCT01014026 ·Status: COMPLETED ·Phase: PHASE3

HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck Cancer

NCT01984359 ·Status: COMPLETED ·Phase: NA

Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC

NCT04564989 ·Status: RECRUITING

HPV in Blood Samples From Cervical Cancer Patients.

NCT03749720 ·Status: COMPLETED ·Phase: NA

Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time

NCT01342978 ·Status: COMPLETED

SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers

NCT05582122 ·Status: RECRUITING ·Phase: PHASE2

Men and Women Offering Understanding of Throat HPV

NCT03644563 ·Status: ACTIVE_NOT_RECRUITING

Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment

NCT04743674 ·Status: RECRUITING

Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer

NCT06362421 ·Status: WITHDRAWN

Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia

NCT00931190 ·Status: COMPLETED

Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia

NCT04274465 ·Status: COMPLETED

Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus

NCT05918510 ·Status: RECRUITING

Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening

NCT07033091 ·Status: RECRUITING ·Phase: NA

Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer

NCT00435214 ·Status: COMPLETED

DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx

NCT00897988 ·Status: COMPLETED

Evaluation of HPV OncoTect ™ for the Etiological Diagnosis of HPV-induced Oropharyngeal Cancers

NCT03604588 ·Status: UNKNOWN ·Phase: NA

A Study to Identify Markers in Blood and Tissue of HPV Clearance

NCT00711815 ·Status: COMPLETED

Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers

NCT05606133 ·Status: RECRUITING ·Phase: NA

Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV

NCT06456112 ·Status: NOT_YET_RECRUITING

Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings

NCT06528184 ·Status: RECRUITING ·Phase: NA

Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study

NCT06115772 ·Status: RECRUITING

Feasibility of Sending a Direct Send HPV Self-sampling Kit to Long-term Screening Non-attenders

NCT04909281 ·Status: COMPLETED